RecruitingNot ApplicableNCT05900414

RAPID AFib Decision Aid for Stroke Prevention in Atrial Fibrillation

Pilot Clinical Trial of the Risk Assessment and Personal Preference to Improve Decisions in Atrial Fibrillation Patient Decision Aid for Stroke Prevention in Atrial Fibrillation: the RAPID AFib Pilot Trial.


Sponsor

University of Calgary

Enrollment

60 participants

Start Date

Apr 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this pilot clinical trial is to evaluate the utility of a new electronic patient decision aid for stroke prevention therapy in patients with atrial fibrillation. The main questions it aims to answer are: Is the patient decision aid acceptable to both patients and physicians? Does the patient decision aid lead to more effective shared decision-making than standard care among patients with atrial fibrillation who are considering stroke prevention therapy? Participants with a recent diagnosis of atrial fibrillation will be enrolled before an upcoming specialist physician visit. Researchers will compare a pre-visit intervention consisting of standard educational materials plus use of the patient decision aid to educational materials alone to see if using the decision aid results in improved shared decision making during the clinic visit.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a decision-support tool (called RAPID AFib) to help people newly diagnosed with atrial fibrillation — an irregular heartbeat — make more informed decisions about taking blood thinners to reduce their stroke risk. **You may be eligible if...** - You have been diagnosed with atrial fibrillation (not caused by a heart valve problem) within the past 12 months - You are 18 or older - You are either not taking blood thinners yet, or have been taking them for less than 90 days - You have an upcoming specialist appointment scheduled in 7–30 days **You may NOT be eligible if...** - Your atrial fibrillation is caused by a mechanical heart valve, rheumatic mitral stenosis, or significant mitral stenosis - You are on dual antiplatelet therapy (e.g., aspirin plus clopidogrel) for a reason unrelated to atrial fibrillation - You already have a separate reason to take blood thinners - You do not have internet access or cannot read English at a Grade 5 level Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALElectronic patient decision aid

Link to website with information about atrial fibrillation treatments, plus access to the web-based patient decision aid to enable shared decision making between patients and their physicians for atrial fibrillation stroke prevention treatments

OTHERInformation

Link to website with information about atrial fibrillation treatments


Locations(2)

Calgary Zone, Alberta Health Services

Calgary, Alberta, Canada

Vita Diagnostics

Calgary, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05900414


Related Trials